Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to 0.08%.

  • Lifecore Biomedical, Inc. \De\'s Return on Capital Employed fell 400.0% to 0.08% in Q2 2025 from the same period last year, while for May 2025 it was 0.08%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.08% for FY2025, which is 400.0% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Return on Capital Employed stood at 0.08% for Q2 2025, which was down 400.0% from 0.09% recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Return on Capital Employed high stood at 0.0% for Q4 2021, and its period low was 0.28% during Q4 2022.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Return on Capital Employed had a median value of 0.08% in 2025 and averaged 0.08%.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Return on Capital Employed plummeted by -2800bps in 2022, and later surged by 1600bps in 2023.
  • Lifecore Biomedical, Inc. \De\'s Return on Capital Employed (Quarter) stood at 0.0% in 2021, then plummeted by -66979bps to 0.28% in 2022, then surged by 59bps to 0.11% in 2023, then skyrocketed by 50bps to 0.06% in 2024, then tumbled by -45bps to 0.08% in 2025.
  • Its Return on Capital Employed stands at 0.08% for Q2 2025, versus 0.09% for Q1 2025 and 0.06% for Q4 2024.